.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Healthtrust
Argus Health
Daiichi Sankyo
UBS
Baxter
Citi
Mallinckrodt
Covington
Fish and Richardson
Express Scripts

Generated: January 18, 2018

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: fludeoxyglucose f-18

« Back to Dashboard

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Biomedcl Res FdnFLUDEOXYGLUCOSE F18fludeoxyglucose f-18INJECTABLE;INTRAVENOUS203710ANDABiomedical Research Foundation of Northwest Louisiana24562-001-3030 mL in 1 VIAL, GLASS (24562-001-30)
Biomedcl Res FdnFLUDEOXYGLUCOSE F18fludeoxyglucose f-18INJECTABLE;INTRAVENOUS203837ANDABiomedical Research Foundation of Northwest Louisiana24562-003-3030 mL in 1 VIAL, GLASS (24562-003-30)
Brigham WomensFLUDEOXYGLUCOSE F18fludeoxyglucose f-18INJECTABLE;INTRAVENOUS203816ANDABRIGHAM AND WOMEN`S HOSPITAL, INC., THE24450-647-3030 mL in 1 VIAL, MULTI-DOSE (24450-647-30)
Cardinal Health 414FLUDEOXYGLUCOSE F18fludeoxyglucose f-18INJECTABLE;INTRAVENOUS203603ANDACardinal Health 414, LLC65857-100-3030 mL in 1 VIAL, GLASS (65857-100-30)
Childrens Hosp MiFLUDEOXYGLUCOSE F18fludeoxyglucose f-18INJECTABLE;INTRAVENOUS204385ANDAChildren's Hospital of Michigan76167-001-3030 mL in 1 VIAL, GLASS (76167-001-30)
CpdcFLUDEOXYGLUCOSE F18fludeoxyglucose f-18INJECTABLE;INTRAVENOUS204525ANDACentre for Probe Development and Commercialization21731-647-032.5 mL in 1 SYRINGE (21731-647-03)
CpdcFLUDEOXYGLUCOSE F18fludeoxyglucose f-18INJECTABLE;INTRAVENOUS204525ANDACentre for Probe Development and Commercialization21731-647-3030 mL in 1 VIAL (21731-647-30)
CpdcFLUDEOXYGLUCOSE F18fludeoxyglucose f-18INJECTABLE;INTRAVENOUS204525ANDACentre for Probe Development and Commercialization21731-647-053.5 mL in 1 SYRINGE (21731-647-05)
CpdcFLUDEOXYGLUCOSE F18fludeoxyglucose f-18INJECTABLE;INTRAVENOUS204525ANDACentre for Probe Development and Commercialization21731-647-1010 mL in 1 VIAL (21731-647-10)
CpdcFLUDEOXYGLUCOSE F18fludeoxyglucose f-18INJECTABLE;INTRAVENOUS204525ANDACentre for Probe Development and Commercialization21731-647-01.8 mL in 1 SYRINGE (21731-647-01)
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Novartis
Healthtrust
Boehringer Ingelheim
Cerilliant
Johnson and Johnson
Queensland Health
Cipla
Moodys
US Department of Justice

Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot